Profile

Business Description

Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable.

The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.

Company Info

Address:
1545 Route 206 South
Suite 302
Bedminster, NJ 07921 US

Telephone:
+1-908-443-1860

Email:
info@matinasbiopharma.com

Industry Classifications

Sector:
Health Care

Industry:
Biotechnology & Drugs

NAICS:
325412 – Pharmaceutical Preparation Manufacturing

SIC:
2834 – Pharmaceutical preparations